Balance Sheet
Cash Flow Statement
AmortizationBeginning Cash BalanceCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in CashChange in Net LoansChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther financing activitiesShare-based CompensationShort-Term Debt repayments
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Abivax (ABVX) Depreciation & Amortization (CF) (2024 - 2025)

Historic Depreciation & Amortization (CF) for Abivax (ABVX) over the last 2 years, with Q3 2025 value amounting to $317983.0.

  • Abivax's Depreciation & Amortization (CF) rose 1818.13% to $317983.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $1.2 million, marking a year-over-year increase of 3321.45%. This contributed to the annual value of $1.2 million for FY2024, which is 5369.96% up from last year.
  • Per Abivax's latest filing, its Depreciation & Amortization (CF) stood at $317983.0 for Q3 2025, which was up 1818.13% from $284121.9 recorded in Q2 2025.
  • Abivax's Depreciation & Amortization (CF)'s 5-year high stood at $393064.0 during Q2 2024, with a 5-year trough of $229222.4 in Q1 2024.